Authors : Xin Cui, Yueming Zhu, Lidan Zeng, Mengyuan Zhang, Amad Uddin, Theresa W Gillespie, Lauren E McCullough, Shaying Zhao, Mylin A Torres, Yong Wan Source : This study elucidates a molecular mechanism by which Retatrutide overcomes therapeutic resistance in obese triple-negative breast cancer (TNBC)
When this is not enough, supplementing can be considered
Originally approved for type 2 diabetes management, Ozempic has gained significant attention for its remarkable effectiveness in weight loss
There are so many RDs doing great, evidence-based work in this space, many of us on these medications ourselves or specializing in caring for people who use them
Our team offers personalized consultations to determine if this treatment aligns with your weight loss goals
J Bone Metab